A university is only as great as its faculty and the College of Pharmacy went all-in on faculty excellence. On Wednesday, April 6, The University of Texas at Austin’s Pharmacy Council honored and celebrated top educators from across the college at its 2022 Teaching Excellence Awards.
Dr. Mo Maniruzzaman's Pharmaceutical Engineering and 3D Printing Labs have received a federal grant from the United States Agency for International Development (USAID) to develop personalized 3D printed non-hormonal intrauterine devices (IUDs). The project’s goal is to increase global access to long-term and effective contraception while minimizing some of its most debilitating side effects.
The UT College of Pharmacy Alumni Association has selected Benjamin McNabb, Pharm.D., Julie Johnson, Pharm.D. and Jeanne D. Waggener, R.Ph. as the 2021 Alumni Award recipients. 2020 and 2021 Alumni Award winners will be honored on November 13, 2021 at the Pharmacy Homecoming Tailgate, generously sponsored by H-E-B.
The College of Pharmacy’s Pharmaceutical Engineering and 3D Printing (PharmE3D) Labs recently earned a three-year $1.5 million National Institutes of Health (NIH) R01 grant to research novel manufacturing technology for complex vaccine formulations for influenza and other emerging infectious diseases.
The college's Pharmaceutical Engineering and 3D Printing (PharmE3D) labs, led by Assistant Professor in Molecular Pharmaceutics and Drug Delivery Mohammed (Mo) Maniruzzaman, Ph.D., has recently earned several national and international awards and scholarships for outstanding research contributions to the field of pharmaceutical science and technology.
The College of Pharmacy Alumni Association seeks nominations for the three awards that honor alumni and friends of the college. The deadline to submit nominations is August 31, 2021 and awards will be presented at the College of Pharmacy Homecoming Tailgate on Saturday, November 13, 2021.
Division Head and Professor of Molecular Pharmaceutics and Drug Delivery Dr. Bill Williams was on KXAN News to talk about promising new data from TFF Pharmaceuticals and Augmenta Bioworks. The companies plan to develop Dr. Williams' thin film freezing technology to better deliver antibody treatment directly to the lungs of COVID patients.